Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biodesix (BDSX) Leases (2022 - 2025)

Biodesix's Leases history spans 4 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Leases rose 69.61% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, up 69.61%, while the annual FY2025 figure was $3.0 million, 69.61% up from the prior year.
  • Leases reached $3.0 million in Q4 2025 per BDSX's latest filing, up from $2.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.5 million in Q3 2022 to a low of $1.2 million in Q1 2022.
  • Average Leases over 4 years is $2.2 million, with a median of $2.0 million recorded in 2022.
  • The largest YoY upside for Leases was 82.83% in 2023 against a maximum downside of 41.31% in 2023.
  • A 4-year view of Leases shows it stood at $3.0 million in 2022, then tumbled by 41.31% to $1.7 million in 2023, then increased by 1.26% to $1.8 million in 2024, then surged by 69.61% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Leases are $3.0 million (Q4 2025), $2.9 million (Q3 2025), and $2.1 million (Q2 2025).